OREANDA-NEWS. Affimed today announced that Dr. Adi Hoess, CEO, will present a corporate overview at the UBS Global Healthcare Conference – New York, to be held May 23-25, 2016.

Dr. Hoess' presentation will take place May 23, 1:00-1:30 p.m. (ET).

Affimed engineers targeted immunotherapies, seeking to cure patients by harnessing the power of innate and adaptive immunity (NK- and T-cells). We are developing single and combination therapies to treat cancers and other life-threatening diseases.